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Abstract 
Introduction: neurologically impaired children frequently experience nutritional disorders and bone health complications. Our aim was firstly to 
analyze a method to interpret bone mineral density (BMD) accurately in neurologically impaired children. Secondly, to determine its relationship 
with the nutritional status and micronutrient levels in order to identify which factors are associated with low BMD. 
Methods: a observational multicenter study was conducted in children with moderate-to-severe neurological impairment. Data collected included: 
medical records, anthropometric measures, hematologic and biochemical evaluation. BMD was measured with Dual-energy X-ray absorptiometry 
and z-scores were calculated adjusting for sex and chronological age. Secondly, BMD z-scores were calculated applying height age (age at which 
the child’s height would be in 2nd percentile) instead of chronological age.
Results: fifty-two children were included (aged 4-16 years). Seventeen patients (32.7%) received feeding by gastrostomy tube. Height and BMI 
z-score were below 2SD in 64% and 31% of patients respectively, with normal mid upper arm circumference and skinfold thickness measure-
ments. Low vitamin-D levels were found in 42% of cases. 50% of patients evidenced low BMD when calculated for chronological age, whereas 
only 34.5% showed BMD z-score <-2 when calculated for height age. No correlation was observed between BMD and vitamin-D levels, weight 
and height z-scores or age when BMD was calculated applying height age.
Conclusions: the prevalence of low BMD is high in neurologically impaired children, and it is probably multifactorial. In these children, we suggest 
adjusting BMD for height age, in order not to over diagnose low BMD.
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Resumen
Introducción: los niños con afectación neurológica con frecuencia presentan trastornos nutricionales y complicaciones óseas. Nuestro objetivo 
fue, en primer lugar, analizar un método para interpretar la densidad mineral ósea (DMO) de forma adecuada en estos pacientes. En segundo lugar, 
determinar la relación de la DMO con el estado nutricional y los niveles de micronutrientes, para determinar qué factores se asocian con baja DMO. 
Métodos: estudio observacional multicéntrico, se incluyeron niños con afectación neurológica moderada-severa. Se recogieron datos clínicos, 
medidas antropométricas y una evaluación hematológica y bioquímica. La DMO fue evaluada mediante densitometría, y se calcularon los z-scores 
según la edad y sexo. En segundo lugar, se recalcularon los z-scores de DMO para la edad talla (edad en la cual la talla del niño se encontraría 
en el percentil 2) en vez de la edad cronológica.
Resultados: se incluyeron 52 niños (4-16 años). Diecisiete pacientes (32,7%) recibían alimentación por gastrostomía. Los z-scores de peso y 
talla estaban por debajo de 2 desviaciones estándar (DE) en el 64% y 31% de los pacientes respectivamente, con normalidad de las mediciones 
de perímetro braquial y pliegues tricipital y subescapular. Los niveles de vitamina D estaban bajos en el 42% de los casos. La mitad de los paci-
entes tenían baja DMO cuando se calculó para la edad cronológica, mientras que solo el 34,5% presentaron DMO por debajo de 2 DE cuando 
se calculó para la edad talla. No observamos correlación entre z-scores de DMO calculados para la edad talla y los niveles de vitamina D, la 
edad o los z-scores de peso y talla. 
Conclusiones: la prevalencia de baja DMO es alta en niños con discapacidad neurológica, y probablemente es multifactorial. En estos niños, 
sugerimos ajustar DMO para la edad talla, para evitar sobrediagnosticar baja DMO.
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Table I. Patients’ characteristics
Patients (n = 52)
Mean age (range) 9.9 (4-16)
Gender male n (%) 33 (63.5%)
Diagnosis n (%)
 Cerebral palsy
  GMFCS III
  GMFCS IV
  GMFCS V
 Genetic diseases
 Neuromuscular diseases
 Epileptic encephalopathies
 Others
40 (77%)
4 (10%)
11 (27.5%)
25 (62.5%)
6 (11.5%)
2 (4%)
1 (2%)
3 (5.5%)
Anticonvulsive treatment n (%) 33 (63.5%)
Treatment with PPI n (%) 30 (58%)
Previous fractures n (%) 8 (15.4%)
Severe mental retardation n (%) 44 (85%)
Nutritional variables n (%)
 Oral feeding
   Supplement with polymeric 
enteral formula 
 Tube feeding
35 (67.3%)
17 (48.5%)
17 (33%)
PPI: proton pump inhibitors.
INTRODUCTION
Patients with severe neurologic diseases frequently expe-
rience nutritional and growth disorders and bone health com-
plications of multifactorial origin, being these more evident 
with increasing motor disorder (1,2). Almost half of these chil-
dren show problems with feeding and malnutrition, frequently 
under-recognized (1,3). Undernutrition can have adverse con-
sequences, including growth failure, greater motor disorder, 
poor bone health, recurrent pneumonia and neurologic worse-
ning with increasing cognitive delay and abnormal behavior (4). 
Among factors that contribute to nutritional disorders in 
children with neurologic disease are oromotor dysfunctions 
that result in insufficient intake, increased losses and feeding 
behavior disorders (5). A frequent problem in these patients is 
osteoporosis related to immobility, undernutrition, insufficient 
intake of calcium, limited solar exposure and treatment with 
antiepileptic drugs. All of them often favor fractures after mi-
nimal trauma (6-8). As a consequence, all of these conditions 
negatively affect the quality of life of the children and their 
caregivers or family (3,9). 
In order to assess bone health, the recommended method 
and most widely available is to evaluate BMD using Dual-ener-
gy X-ray absorptiometry scan (DXA). During childhood, BMD 
changes according age and sex, so we need to express the 
results as z-score. Because BMD is a two-dimensional mea-
surement, it is a problem to interpret the results in the growing 
skeleton, as BMD measurements are affected by body size 
(10). Currently, there is no consensus about which method 
we must apply to adjust BMD for height in order to avoid over 
and under diagnosis of low BMD. There have been several 
approaches, but most of them are difficult to perform in clinical 
practice. 
With this perspective, the aim of our study was firstly to 
analyze a method to determine bone mineral density (BMD) 
accurately in neurologically impaired children. Secondly, to 
determine the relationship between BMD, the nutritional status 
and micronutrient levels, in order to identify which factors are 
associated with low BMD. 
MATERIAL AND METHODS
An observational multicenter study was conducted. Data 
was collected between September 2014 and September 2016.
PATIENTS
Patients under 16 years of age with neurological impairment 
were recruited. They were controlled in Pediatric Gastroentero-
logy and Nutrition outpatient clinics of five hospitals. Patients 
with the following moderate or severe motor affectation were 
included: a) cerebral palsy (CP) grade III, IV or V classified 
according to the Gross Motor Function Classification System 
(GMFCS) (11); b) patients with severe neurological disorders 
that could not walk around without help (Table I). In both ca-
ses, written parental consent and approval from the Hospitals’ 
Ethics Committee were obtained. 
Parameters recorded were: age, gender, underlying disease, 
medications, questions to assess swallowing problems, and 
feeding method (oral or tube-feeding). Factors related with 
BMD, mineral and vitamin D supplementation, history of 
bone fractures and treatment with antiepileptic drugs were 
assessed. The intellectual delay was classified according to 
the diagnostic criteria of the DSM-IV-TR, categorizing children 
with or without severe mental retardation (12).
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ANTHROPOMETRIC ASSESSMENT
The weight was obtained from the child either naked or in 
underwear. Given that these children are not capable of standing 
with stability, they were weighed together with the caregiver, 
whose weight was later subtracted (Clinical electronic scales 
Seca® model 769, Germany) (4,5). Length was measured in a 
supine position using an anthropometer or horizontal measuring 
table (Holtain® stadiometer, United Kingdom). In children who 
showed contractures, spasticity or severe scoliosis, as the 
measurement could not be obtained this way, measurement of 
segmental lengths was recorded on the left side of the body and 
repeated, achieving the average of both measurements. In children 
with some disparities, the measurements were obtained from 
the least affected side. The upper arm length (UAL) (distance 
from the acromion to the radial head) and the tibial length (TL) 
(distance from the supermedial edge of the tibia to the inferior 
edge of the medial malleolus) were measured (13). In these 
children, the stature (S) was calculated from the TL using the 
following formula: S = (3.26 x TL) +30.8 (14). In these patients, 
the body mass index (BMI) was not calculated so as not to magnify 
the possible error of the estimated S calculation when squared.
Other measurements recorded were mid upper arm circum-
ference (MUAC) (with inextensible tape measure) and triceps 
and subscapular skinfolds thickness using a skinfold caliper 
(0.2 mm precision) (Holtain®, United Kingdom), obtaining the 
average of three measurements. 
The anthropometric data was converted into z-score for age 
and sex according to the references of the WHO for children 
under 5 years of age (15). For those older than 5, the weight, 
size and BMI z-score were calculated according to references 
of the WHO (16), applying references of Frisancho for MUAC 
and skinfold thickness (17).
HEMATOLOGIC 
AND BIOCHEMICAL EVALUATION
During the initial evaluation of each patient, hematologic 
and biochemical analyses were performed. The biochemical 
evaluation included measuring levels of albumin, prealbumin, 
calcium, phosphorous, magnesium, alkaline phosphatases, 
25OH vitamin D, parathyroid hormone (PTH), vitamin B12, fo-
late, iron, ferritin and zinc. A concentration of 25OH vitamin D 
below 30 ng/mL was considered insufficient, and marked as 
deficiency if below 20 ng/mL (18). Zinc was considered below 
normal when the levels were under 70 µg/dL (19).
ASSESSMENT OF BONE HEALTH
BMD was evaluated at lumbar spine (L2-L4) through DXA 
(Norland DXA®). Firstly, the measurements obtained (g/cm2) 
were converted into z-scores normalized by chronological age 
and sex according to the previously published data (20). Se-
condly, BMD z-score were calculated substituting chronologi-
cal age for height age. Height age was calculated for children 
with height below z-score <-2 as the age at which the child’s 
height would be in 2nd percentile. For children with height 
greater than 2nd percentile, height age was assigned the same 
as chronological age.
DATA ANALYSIS
Descriptive statistics were calculated for the demographic, 
clinical characteristics, and biochemical analysis. Indepen-
dent sample one-way ANOVAs were undertaken to determine 
the differences in anthropometric characteristics between 
patients with or without gastrostomy. Pearson’s correlations 
were calculated to determine the level of association be-
tween BMD (calculated in the two ways: chronological age 
and height age), age, anthropometric z-scores and vitamin D 
levels. Hierarchical multiple regression analyses were con-
ducted with the BMD and anthropometric z-scores. Statistics 
were generated with a standard statistical package IBM SPSS 
Statistics for Windows, version 23.0 (IBM Corp., Armonk, 
N.Y., USA). The two-sided threshold for statistical significance 
was set at p < 0.05.
RESULTS
A total of 52 patients were included (patients’ main charac-
teristics in table I). The mean age was 9.9 years (range 4-16), 
and 63.5% of sample were boys. Among these patients, the 
majority presented severe motor impairment, whereas 85% 
suffered from profound mental retardation. The main diag-
nostic obtained was CP (77%). Anticonvulsive drugs were 
prescribed in 63.5% of cases, and proton pump inhibitors 
(PPI) in 58%. Most children (67.3%) received oral feeding, 
17 of them (48.5%) with supplement in the form of polymeric 
formula. Seventeen patients (33%) were fed by gastrostomy 
tube. Twelve children (23%) received oral supplement with 
vitamin D at the time of the study. 
ANTHROPOMETRIC RESULTS
The anthropometric results are showed in table II. In 63% 
of children, the weight z-score was below 2SD; height z-sco-
re was below 2SD in 64% patients; and BMI resulted below 
2SD in 31% children. No differences between patients with or 
without GT were shown except in height for age. The stature 
was not possible to obtain in a direct way in 16 children and 
had to be calculated by estimating from the TL.
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HEMATOLOGICAL 
AND BIOCHEMICAL RESULTS 
Iron deficiency anemia was detected in 3 patients (2 of them 
at a pubertal age). The biochemical study showed that 19 chil-
dren (36.5%) had vitamin D levels lower than recommended 
(25% insufficiency and 11.5% deficiency), while levels of cal-
cium, phosphorus, magnesium, alkaline phosphatase, vitamin 
B12 and folate remained normal in every case. PTH levels were 
not included in the results because we have results only in 40% 
of the patients, showing normal levels in all of them. The albumin 
was normal, while the prealbumin was diminished in 18% of 
patients. Levels of zinc were found to be diminished in 20% of 
patients (Table III).
BONE HEALTH
A total of 15.4% of patients included in the study had a history 
of bone fractures. BMD was lower in patients with history of 
bone fractures, but it was not statistically significant (p = 0.277).
When calculated for chronological age, 26 patients (50%) 
showed a BMD z-score <-2 (mean -1.73 ± 1.25), whereas 
only 18 (34.5%) showed BMD z-score <-2 when calculated for 
height age (mean -1.44 ± 1.27). 
The associations between BMD and other variables are pre-
sented in table IV. When calculated for chronological age, BMD 
was significantly correlated with z-score weight (r = 0.453, 
p = 0.001), and z-score height (r = 0.340, p = 0.042), but 
not with BMI z-score. However, no correlation was found when 
BMD calculated applying height age. No relation was observed 
between BMD and the levels of vitamin D or age.
Table III. Biochemical analysis
Micronutrient Mean SD
Children 
presenting 
deficiency (%)
Calcium (mg/dL) 9.9 0.5 0
Phosphorous (mg/dL) 4.5 0.7 0
Magnesium (mg/dL) 1.8 0.6 0
Alkaline phosphatase (UI/L) 190 54 0
Vitamin B12 (pg/mL) 973 538 0
Albumin (g/dL) 4.3 0.4 0
Iron (µg/dL) 74.7 35 6
Ferritin (ng/mL) 46.5 45 6
Folate (ng/mL) 11.8 5.5 0
25OH-vitamin D (ng/mL) 36.7 15.5 36.5
Prealbumin (mg/dL) 19.3 4.6 18
Zinc (µg/dL) 86.8 38 20
SD: standard deviation.
Table II. Anthropometric characteristics
Z-score
Orally-fed
patients
(n = 35)
Gastrostomy-
fed patients
(n = 17)
p-value
Weight for age, 
M (SD)
-2.70 (1.50) -2.29 (1.71) 0.413
Height for age, 
M (SD)
-2.12 (1.54) -2.97 (1.50) 0.038
BMI for age,  
M (SD)
-1.43 (1.82)* -0.84 (1.95)** 0.327
Arm 
circumference, 
M (SD)
-0.86 (1.16) -0.32 (1.30) 0.192
Triceps skinfold, 
M (SD)
-0.36 (0.96) 0.26 (1.30) 0.142
Subscapular 
skinfold, M (SD)
0.08 (0.64) 0.24 (0.86) 0.184
M: mean; SD: standard deviation. *n = 22; **n = 14.
Table IV. Pearson’s correlations between 
BMD, anthropometric z-score, age and 
vitamin D level
Variables
BMD for 
chronological 
age
BMD for 
age height
Z-score Height for age 0.866** 0.082
Z-score Weight for age 0.453** 0.206
Z-score BMI for age 0.229 0.139
Age -0.113 0.125
Vitamin D level 0.214 0.084
**Correlation is significant at 0.01 level (two-tailed). *Correlation is significant 
at the 0.05 level (two-tailed).
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DISCUSSION
Nutritional support in children with neurological disabilities 
is considered an important factor to improve global outcome, 
reduce complications and promote the quality of life of both the 
patient and their parents/caregivers. As a part of their nutri-
tional assessment, bone health should be evaluated, because 
children with disability of a neurological origin frequently feature 
lower BMD compared with healthy children of the same age 
and gender, resulting in an increased risk of fractures (21,22). 
The objective of bone health assessment in clinical practice is 
to determine whose children are at risk, in order to establish a 
treatment before suffering fractures. The recommended method 
is measuring BMD with DXA. BMD values must be expressed in 
age and sex specific z-scores. Additionally, it is well known that 
DXA measures of BMD are confounded by short stature (23), 
but there is no consensus about how to adjust these results for 
bone size. 
It has been proven that neurologically impaired children grow 
slower than children of the same age and gender without chro-
nic pathology (24-26), and these differences increase with age 
(8). This is due to both nutritional and non-nutritional factors, 
such as genetic and endocrine factors. Our anthropometric re-
sults show average z-scores for height under 2 SD, suggestive 
of stunting, so the need to adjust the results for body size be-
comes even more important.
Some authors suggest adjusting BMD for height age, which 
is the age at which child’s height is the median height-for-age 
on the growth chart (27). A limitation of this procedure is that it 
doesn’t consider pubertal maturation. The calculation of bone 
mineral apparent density (BMAD) adjusted for age is also pro-
posed, but this is a complicated procedure to perform in clinical 
practice (28). We suggest adjusting BMD for height age, but 
taking the age corresponding to 2nd percentile, because it is 
the lower limit of normality considered by WHO. In our opinion, 
taking the median (50th percentile) as a reference is an unrea-
listic goal because these children have a height well below this 
parameter, thus the height for 50th percentile is far from reality.
In our findings, half of the sample features exhibited low 
BMD according to chronological age, with a z-score less than 
-2 SD. However, when calculated for height age (age at which 
the child’s height would be in 2nd percentile), this percentage 
decreased to 34.5%. These results show that not adjusting for 
height may result in over diagnosing low BMD.
Low BMD is known to be associated with a higher risk of 
fractures (29), thus monitoring and follow up are important. As 
previously mentioned, fractures are frequent in patients with 
severe or moderate neurological affectation, and those that 
have indeed had a fracture have an increased risk of having 
subsequent ones (7,30). In our series we have found 15.4% of 
patients who experienced a fracture in the past, which is similar 
to previously published data (30,31) and it is probably due to 
multiple factors that can influence bone health in a negative way 
(32). Some risk factors that these patients present are under-
nutrition, feeding disorders, age, history of previous fractures, 
immobility, and antiepileptic treatment (10,33-35). 
In our patients, it was noted a high prevalence of epilepsy 
(63.5%), which requires specific drugs that can contribute to 
bone disorders. Feeding problems in children with neurological 
diseases can produce deficiencies at micronutrient level. Thus, 
their deficiencies in many cases can be subclinical, being able 
to affect different areas (36). Therefore, it is crucial to carry 
out a periodic monitoring and control of these aspects. In our 
study, we have found a high prevalence of vitamin D and zinc 
deficiency. Regarding the definition of lack of vitamin D in 
infancy, in 2013 the ESPGHAN Committee on Nutrition consi-
dered levels of 250H-vitamin D below 50 nmol/L (equivalent 
to 20 ng/ml) as deficient and levels below 25 nmol/L (10 
ng/ml) as severe deficiency, taking into account that these 
recommendations are for healthy children (37). In the same 
way, Munns et al., in a global consensus recommendations on 
prevention and management of nutritional rickets published in 
2016, consider levels below 50 nmol/L as insufficiency, and 
below 30 nmol/L as deficiency (38). Nevertheless, other au-
thors consider insufficient levels between 50-80 nmol/L (20-
30 ng/ml) and deficiency levels below 50 nmol/L (< 20 ng/
ml) (18). Considering the multiple risk factors for bone health 
in these children, it seems more convenient to contemplate 
the latter. It should be noted the normality at biochemical level 
of the minerals (calcium, phosphorus, magnesium), alkaline 
phosphatase, vitamin B12 and folate in all cases, supporting 
what was described in other series (39). However, it has to 
be taken into account that the normality of the levels of these 
minerals in blood do not reflect fully the state of the entire or-
ganism, given that it deals with important components at blood 
level and that they are strongly regulated by homeostasis (36). 
It should be considered that many of the risk factors for 
bone health that these patients have are interrelated, which 
makes it difficult to determine their contribution in an isolated 
way. In our patients, after performing Pearson’s correlation, we 
found association between the BMD z-score and the z-score 
of weight and height. However, this relation is not maintained 
after adjusting BMD for height. The association we observed 
between height, weight and BMD is most likely an artefact of 
the short stature in these children, rather than a true effect 
of undernutrition. Consequently, it disappears after adjusting 
BMD measurements for height age. No association with age or 
vitamin D levels were found, despite being described previously 
in the literature (6).
To this effect, accurate reporting of these patients’ clinical and 
laboratory data throughout their follow-up can be of interest to 
paediatricians responsible for these patients.
Despite the relevance of this study’s findings, several limita-
tions must be acknowledged. Firstly, the transversal nature of 
this study limits the ability to withdraw causational or directional 
conclusions. Secondly, since the sample comprises children su-
ffering from neurological diseases, results may not be readily 
applicable to children with other underlying diseases. Finally, 
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the relatively small sample size imposes an overall limitation to 
result extrapolation. 
In conclusion, these results suggest the need to perform a 
periodic follow up of the nutritional status of children with neuro-
logical impairment as an integral part of their health care, aiding 
to early detect nutritional disorders so that they will benefit from 
precocious treatment (5). During the follow up it is important to 
monitor the levels of vitamin D and zinc, as their lack is frequent 
but can be corrected, and to perform periodic controls of DXA 
to try to early detect changes in the BMD before they suffer 
fractures. We suggest calculating BMD z-score according sex 
and adjusting age at which height is at 2nd percentile if lower, to 
avoid to over diagnose low BMD. 
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